Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 22.3% | 29.3% | (39.5%) | 35.9% | 35.9% | 38.9% | 34.7% | 24.5% | 18.7% | 20.4% | 55.1% | 52.5% | 31.3% | 9.8% | 10.5% | 8.6% | 10.0% | 9.4% | 11.2% | 12.4% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 19.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Capital Employed (ROCE) for Gilead Sciences, Inc. have been 13.4% over the past three years, and 11.6% over the past five years.
As of today, Gilead Sciences, Inc.'s Return on Capital Employed (ROCE) is 19.4%, which is higher than industry median of 12.8%. It indicates that Gilead Sciences, Inc.'s Return on Capital Employed (ROCE) is Good.